Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Core EBITDA Growth

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 17.6827.6932.55-13.1679.82

What is the latest Core EBITDA Growth ratio of MARKSANS PHARMA ?

The latest Core EBITDA Growth ratio of MARKSANS PHARMA is 17.68 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202517.68
Mar202427.69
Mar202332.55
Mar2022-13.16
Mar202179.82

How is Core EBITDA Growth of MARKSANS PHARMA Trending?

Years Core EBITDA Growth % Change
Mar2025 17.68
-36.15
Mar2024 27.69
-14.93
Mar2023 32.55
Positive
Mar2022 -13.16
Negative
Mar2021 79.82 -

Other Financial Ratios of MARKSANS PHARMA


Compare Core EBITDA Growth ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹11,758.3 Cr 5.3% -4.6% 6.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹477,408.0 Cr 1.8% 6.8% 17.8% Stock Analytics
DIVIS LABORATORIES ₹206,906.0 Cr 6.7% 18.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,521.0 Cr -3.7% 5.5% 39.8% Stock Analytics
CIPLA ₹119,032.0 Cr 5.7% 0.6% -1.4% Stock Analytics
DR REDDYS LABORATORIES ₹95,420.1 Cr -2% -15.8% -8.4% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

5.3%

-4.6%

6.1%

SENSEX

1.2%

1.2%

-5.5%


You may also like the below Video Courses